Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy

[1]  Jing Chen,et al.  An in situ hydrogel-mediated chemo-immunometabolic cancer therapy , 2022, Nature Communications.

[2]  Heliang Yao,et al.  Microbiotic nanomedicine for tumor-specific chemotherapy-synergized innate/adaptive antitumor immunity , 2022, Nano Today.

[3]  Yu Chen,et al.  Ultrasound-Controlled CRISPR/Cas9 System Augments Sonodynamic Therapy of Hepatocellular Carcinoma , 2021, ACS Central Science.

[4]  Hui Hu,et al.  CRISPR/Cas9‐2D Silicene Gene‐Editing Nanosystem for Remote NIR‐II‐Induced Tumor Microenvironment Reprogramming and Augmented Photonic Tumor Ablation , 2021, Advanced Functional Materials.

[5]  Weilin Wang,et al.  Plasmon‐Driven Catalytic Chemotherapy Augments Cancer Immunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway , 2021, Advanced materials.

[6]  R. Weichselbaum,et al.  Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade , 2021, Gut.

[7]  Lukas Farbiak,et al.  Membrane destabilizing ionizable phospholipids for organ selective mRNA delivery and CRISPR/Cas gene editing , 2021, Nature Materials.

[8]  J. Stein,et al.  Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA , 2020, Nature.

[9]  Yi Zhang,et al.  HMGB1 in inflammation and cancer , 2020, Journal of Hematology & Oncology.

[10]  Jianlin Shi,et al.  Nanomaterials/microorganism-integrated microbiotic nanomedicine , 2020, Nano Today.

[11]  M. Horton,et al.  Targeting metabolism to regulate immune responses in autoimmunity and cancer , 2019, Nature Reviews Drug Discovery.

[12]  Nadinath B. Nillegoda,et al.  The Hsp70 chaperone network , 2019, Nature Reviews Molecular Cell Biology.

[13]  H. Kiem,et al.  Targeted homology-directed repair in blood stem and progenitor cells with CRISPR nanoformulations , 2019, Nature Materials.

[14]  Yongchun Pan,et al.  Near-infrared upconversion–activated CRISPR-Cas9 system: A remote-controlled gene editing platform , 2019, Science Advances.

[15]  G. Prendergast,et al.  Immune control by amino acid catabolism during tumorigenesis and therapy , 2019, Nature Reviews Cancer.

[16]  K. Lundstrom.  Viral Vectors in Gene Therapy , 2018, Diseases.

[17]  Levi A Garraway,et al.  A Convergence-Based Framework for Cancer Drug Resistance. , 2018, Cancer cell.

[18]  R. Weinberg,et al.  Understanding the tumor immune microenvironment (TIME) for effective therapy , 2018, Nature Medicine.

[19]  Fajr A. Aleisa,et al.  Endosomal Escape and Delivery of CRISPR/Cas9 Genome Editing Machinery Enabled by Nanoscale Zeolitic Imidazolate Framework. , 2018, Journal of the American Chemical Society.

[20]  G. Banna,et al.  Lactobacillus rhamnosus GG: An Overview to Explore the Rationale of Its Use in Cancer , 2017, Front. Pharmacol..

[21]  Gang Bao,et al.  CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery. , 2017, Chemical reviews.

[22]  C. Crews,et al.  Waste disposal—An attractive strategy for cancer therapy , 2017, Science.

[23]  Nina Bhardwaj,et al.  Dendritic cell-based immunotherapy , 2016, Cell Research.

[24]  J. Rathmell,et al.  A guide to immunometabolism for immunologists , 2016, Nature Reviews Immunology.

[25]  C. Melief,et al.  Vaccines for established cancer: overcoming the challenges posed by immune evasion , 2016, Nature Reviews Cancer.

[26]  Jean-Pierre Gillet,et al.  Toward a Better Understanding of the Complexity of Cancer Drug Resistance. , 2016, Annual review of pharmacology and toxicology.

[27]  J. Joung,et al.  High-fidelity CRISPR-Cas9 variants with undetectable genome-wide off-targets , 2015, Nature.

[28]  David R. Liu,et al.  Discovery and characterization of a peptide that enhances endosomal escape of delivered proteins in vitro and in vivo. , 2015, Journal of the American Chemical Society.

[29]  Luigi Naldini,et al.  Gene therapy returns to centre stage , 2015, Nature.

[30]  V. Hornung,et al.  Structural and functional analysis reveals that human OASL binds dsRNA to enhance RIG-I signaling , 2015, Nucleic acids research.

[31]  P. Sharma,et al.  The future of immune checkpoint therapy , 2015, Science.

[32]  D. Fearon,et al.  T cell exclusion, immune privilege, and the tumor microenvironment , 2015, Science.

[33]  Alexandro E. Trevino,et al.  Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex , 2014, Nature.

[34]  C. Coyne,et al.  Mechanisms of MAVS regulation at the mitochondrial membrane. , 2013, Journal of molecular biology.

[35]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[36]  Abhishek D. Garg,et al.  Immunogenic cell death and DAMPs in cancer therapy , 2012, Nature Reviews Cancer.

[37]  James Versalovic,et al.  Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. , 2009, Gastroenterology.

[38]  Mark E. Davis,et al.  Imidazole groups on a linear, cyclodextrin-containing polycation produce enhanced gene delivery via multiple processes. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[39]  A. Gasbarrini,et al.  Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis , 2006, Alimentary pharmacology & therapeutics.

[40]  J. Peterse,et al.  Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.

[41]  Weiping Zou,et al.  Immunosuppressive networks in the tumour environment and their therapeutic relevance , 2005, Nature Reviews Cancer.

[42]  G. Prendergast,et al.  Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy , 2005, Nature Medicine.

[43]  G. Salvesen,et al.  Mechanisms of caspase activation. , 2003, Current opinion in cell biology.

[44]  Mark A. Kay,et al.  Progress and problems with the use of viral vectors for gene therapy , 2003, Nature Reviews Genetics.

[45]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.